NCT04910893View on ClinicalTrials.gov

Cytokine Adsorption in Severe, Refractory Septic Shock

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 27, 2014

Primary Completion Date

August 24, 2018

Study Completion Date

December 31, 2018

Conditions
Septic ShockCytokine Storm
Interventions
DEVICE

Cytokine Adsorption

Cytokine adsorption therapy will be provided continuously for 72 hours by means of the CytoSorb® (CytoSorbents Corporation, Monmouth Junction, USA) column, run in series to a veno-venous continuous hemodialysis system, which will be exchanged every 24 hours.

OTHER

Standard of Care

Standard intensive care of patients suffering septic shock

All Listed Sponsors
lead

University of Zurich

OTHER

collaborator

CytoSorbents Europe GmbH

INDUSTRY

NCT04910893 - Cytokine Adsorption in Severe, Refractory Septic Shock | Biotech Hunter | Biotech Hunter